Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German Government Joins Superbug Fight With €40m CARB-X Investment

Executive Summary

Germany’s Ministry of Education and Research has pledged €40m over four years to the antibacterial accelerator CARB-X, part of an overall €500m the country has committed to fighting superbugs in the next decade.

Advertisement

Related Content

Vedanta Receives Cash Injection To Proceed With Microbiome-Derived Pipeline
Four Early-Stage Antibacterial Drugs To Watch: Highlights From IDWeek
REPAIR Is Trying To Fix The Antibiotic Gap Left By Industry
Brits Lead Charge In Global Battle Against Antimicrobial Resistant Superbugs
Iterum Therapeutics Focused On First Oral Penem

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC124905

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel